| Sana Budhani, DO | |
|
4700 Alliance Blvd., Suite 400, Plano, TX 75093 | |
| (469) 814-6631 | |
| (469) 814-3110 |
| Full Name | Sana Budhani |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Experience | 12 Years |
| Location | 4700 Alliance Blvd., Plano, Texas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023374055 | NPI | - | NPPES |
| Q4126 | Other | TX | MEDICAL LICENSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | Q4126 (Texas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Baylor Scott & White Medical Center Plano | Plano, TX | Hospital |
| Baylor Scott & White The Heart Hospital - Plano | Plano, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Healthtexas Provider Network | 1355254210 | 1810 |
News Archive
Elsevier, a world-leading provider of scientific, technical and medical information products and services today announced the publication of an article in the December issue of Reproductive BioMedicine Online (www.rbmonline.com) about miscarriage rates following IVF treatment with frozen thawed embryos which may revolutionize clinical and laboratory practice.
Periodontitis, a common inflammatory disease in which gum tissue separates from teeth, leads to accumulation of bacteria and potential bone and tooth loss. Although traditional treatments concentrate on the bacterial infection, more recent strategies target the inflammatory response.
Young people considering a career in medicine will receive expert advice this weekend to help them on the route to achieving their ambitions and to consider psychiatry as an exciting medical discipline.
Knowing the environmental and human-related variables that characterize the favorable areas for the incidence of the West Nile virus, a flavivirus that is transmitted from birds to humans by mosquitoes, is essential to identify those places in Europe at high risk of experiencing outbreaks, even before these are registered, thus enabling preventive measures to be taken.
ImmuPharma PLC the specialist discovery and development pharmaceutical company is pleased to announce today the final results from a Phase IIb trial of LUPUZOR™ in active patients with Systemic Lupus Erythematosus (SLE). Lupuzor™ administered at 200 mcg once-a-month for 3 months plus standard of care achieved a clinically significant improvement in patient response rate as measured by the combined score compared to placebo plus standard of care.
› Verified 8 days ago
| Entity Name | Health Texas-dallas Diagnostic Association |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1245235886 PECOS PAC ID: 6204817398 Enrollment ID: O20040525001513 |
News Archive
Elsevier, a world-leading provider of scientific, technical and medical information products and services today announced the publication of an article in the December issue of Reproductive BioMedicine Online (www.rbmonline.com) about miscarriage rates following IVF treatment with frozen thawed embryos which may revolutionize clinical and laboratory practice.
Periodontitis, a common inflammatory disease in which gum tissue separates from teeth, leads to accumulation of bacteria and potential bone and tooth loss. Although traditional treatments concentrate on the bacterial infection, more recent strategies target the inflammatory response.
Young people considering a career in medicine will receive expert advice this weekend to help them on the route to achieving their ambitions and to consider psychiatry as an exciting medical discipline.
Knowing the environmental and human-related variables that characterize the favorable areas for the incidence of the West Nile virus, a flavivirus that is transmitted from birds to humans by mosquitoes, is essential to identify those places in Europe at high risk of experiencing outbreaks, even before these are registered, thus enabling preventive measures to be taken.
ImmuPharma PLC the specialist discovery and development pharmaceutical company is pleased to announce today the final results from a Phase IIb trial of LUPUZOR™ in active patients with Systemic Lupus Erythematosus (SLE). Lupuzor™ administered at 200 mcg once-a-month for 3 months plus standard of care achieved a clinically significant improvement in patient response rate as measured by the combined score compared to placebo plus standard of care.
› Verified 8 days ago
| Entity Name | Healthtexas Provider Network |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760488936 PECOS PAC ID: 1355254210 Enrollment ID: O20040727001187 |
News Archive
Elsevier, a world-leading provider of scientific, technical and medical information products and services today announced the publication of an article in the December issue of Reproductive BioMedicine Online (www.rbmonline.com) about miscarriage rates following IVF treatment with frozen thawed embryos which may revolutionize clinical and laboratory practice.
Periodontitis, a common inflammatory disease in which gum tissue separates from teeth, leads to accumulation of bacteria and potential bone and tooth loss. Although traditional treatments concentrate on the bacterial infection, more recent strategies target the inflammatory response.
Young people considering a career in medicine will receive expert advice this weekend to help them on the route to achieving their ambitions and to consider psychiatry as an exciting medical discipline.
Knowing the environmental and human-related variables that characterize the favorable areas for the incidence of the West Nile virus, a flavivirus that is transmitted from birds to humans by mosquitoes, is essential to identify those places in Europe at high risk of experiencing outbreaks, even before these are registered, thus enabling preventive measures to be taken.
ImmuPharma PLC the specialist discovery and development pharmaceutical company is pleased to announce today the final results from a Phase IIb trial of LUPUZOR™ in active patients with Systemic Lupus Erythematosus (SLE). Lupuzor™ administered at 200 mcg once-a-month for 3 months plus standard of care achieved a clinically significant improvement in patient response rate as measured by the combined score compared to placebo plus standard of care.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Sana Budhani, DO 4700 Alliance Blvd., Suite 400, Plano, TX 75093 Ph: (469) 814-6631 | Sana Budhani, DO 4700 Alliance Blvd., Suite 400, Plano, TX 75093 Ph: (469) 814-6631 |
News Archive
Elsevier, a world-leading provider of scientific, technical and medical information products and services today announced the publication of an article in the December issue of Reproductive BioMedicine Online (www.rbmonline.com) about miscarriage rates following IVF treatment with frozen thawed embryos which may revolutionize clinical and laboratory practice.
Periodontitis, a common inflammatory disease in which gum tissue separates from teeth, leads to accumulation of bacteria and potential bone and tooth loss. Although traditional treatments concentrate on the bacterial infection, more recent strategies target the inflammatory response.
Young people considering a career in medicine will receive expert advice this weekend to help them on the route to achieving their ambitions and to consider psychiatry as an exciting medical discipline.
Knowing the environmental and human-related variables that characterize the favorable areas for the incidence of the West Nile virus, a flavivirus that is transmitted from birds to humans by mosquitoes, is essential to identify those places in Europe at high risk of experiencing outbreaks, even before these are registered, thus enabling preventive measures to be taken.
ImmuPharma PLC the specialist discovery and development pharmaceutical company is pleased to announce today the final results from a Phase IIb trial of LUPUZOR™ in active patients with Systemic Lupus Erythematosus (SLE). Lupuzor™ administered at 200 mcg once-a-month for 3 months plus standard of care achieved a clinically significant improvement in patient response rate as measured by the combined score compared to placebo plus standard of care.
› Verified 8 days ago
Yinghui Liu, MD, PHD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 4020 Hedgcoxe Rd, Ste 700, Plano, TX 75024 Phone: 972-618-7800 Fax: 972-618-7900 | |
Dr. Mukesh Kumar D Delvadiya, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 6300 W. Parker Road, Suite 123, Mob Ii, Plano, TX 75093 Phone: 972-398-2899 Fax: 972-398-2837 | |
Dr. Ashesh Bakulesh Parikh, D.O. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 6300 W Parker Rd Ste 322, Plano, TX 75093 Phone: 972-981-7870 Fax: 972-981-7886 | |
Sean Allan Townsend, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 4716 Alliance Blvd, Suite 500, Plano, TX 75093 Phone: 469-800-6000 Fax: 469-800-6052 | |
Dr. Vijay Sitharam Ramanath, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 6124 W Parker Rd, Suite 536, Plano, TX 75093 Phone: 972-378-9560 Fax: 844-290-4363 | |
Samuel Afenir Piga, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 3105 W 15th St, Suite E, Plano, TX 75075 Phone: 469-467-9755 Fax: 972-801-9917 | |
Dr. Maria Love Lee, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 6200 W Parker Rd, Plano, TX 75093 Phone: 972-293-5151 Fax: 972-981-3967 |